Pal, Ravi
Rudas, Akos
Williams, Tiffany
Chiang, Jeffrey N.
Barney, Anna
Cannesson, Maxime
Funding for this research was provided by:
This work was supported by the National Institutes of Health (R01EB029751 and R01HL144692)
This work was supported by the National Institutes of Health (R01EB029751 and R01HL144692)
This work was supported by the National Institutes of Health (R01EB029751 and R01HL144692)
This work was supported by the National Institutes of Health (R01EB029751 and R01HL144692)
This work was supported by the National Institutes of Health (R01EB029751 and R01HL144692)
This work was supported by the National Institutes of Health (R01EB029751 and R01HL144692)
Article History
Received: 3 July 2025
Accepted: 28 October 2025
First Online: 24 November 2025
Competing interests
: Dr. Cannesson is a consultant for Edwards Lifesciences and Masimo Corp, and has funded research from Edwards Lifesciences and Masimo Corp. He is also the founder of Sironis and Perceptive Medical and he owns patents and receives royalties for closed loop hemodynamic management technologies that have been licensed to Edwards Lifesciences. All the remaining authors declare no conflict of interest.